期刊文献+

miR-181a和miR-181b抑制胶质瘤细胞的增殖和侵袭 被引量:2

Effects of miR - 181a and miR - 181b on proliferation and invasion of glioma cells
原文传递
导出
摘要 目的探讨miR-181a和miR-181b对胶质瘤细胞增殖和侵袭等影响。方法通过实时荧光定量PCR检测miR-181a和miR-181b在胶质瘤组织和细胞株中的表达情况。我们合成miR-181a和miR-181b寡聚核苷酸及构建pre—miR-181a和pre—miR-181b表达载体,转染胶质瘤细胞,通过MTF、Transwell实验、流式检测和软琼脂实验,观察上调miR-181a和miR-181b表达后对胶质瘤细胞增殖、侵袭、转化能力和细胞凋亡的影响。结果miR-181a和miR-181b在胶质瘤组织和细胞株较正常脑组织均呈过低表达;miR-181a表达水平与胶质瘤等级呈负相关。上调miR-181a和miR-181b表达能有效抑制胶质瘤细胞生长,降低其转化和侵袭能力,诱导凋亡。结论胶质瘤中异常低表达的miR-181a和miR-181b可能发挥着肿瘤抑制因子作用。 Objective To study the effects of miR - 181a and miR - 181b overexpression on proliferation, transformation, apoptosis, and invasion of glioma cells. Methods The relative expression of miR - 181a and miR - 181b in human glioma tissue samples and glioma cell lines were performed by real - time quantification RT -PCR. We chemically synthesized miR -181a and miR- 181b oligonucleotides and constructed expression vectors for pre - miR - 181a and pre - miR - 181b. The effects of the proliferation, transformation, invasion, and apoptosis of miR -181a and miR- 181b on transfected cells were evaluated via MTT assay, soft agar colony assay, transwell assay and flow cytometric method. Results MiR - 181a and miR - 181b were strongly down - regulated in all glioma samples and glioma cell lines, and miR - 181a expression was negatively correlated with tumor grades. Overexpression of miR - 181a and miR - 181b could effectively lead to glioma cells growth suppression, transformation inhibition, apoptosis increase, and invasion reduction. Conclusion The aberrantly down - regulated miR - 181a and miR - 181b may act as tumor suppressors in human glioma.
出处 《中华神经外科杂志》 CSCD 北大核心 2010年第4期365-368,共4页 Chinese Journal of Neurosurgery
基金 基金项目:国家自然科学基金项目资助(30672165,30772231,30872657):江苏省医学重点人才项目(RC2007061)
关键词 miR-181a miR-181b 增殖 侵袭 神经胶质瘤 MiR- 181a MiR- 181b Proliferation Invasion Glioma
  • 相关文献

参考文献5

二级参考文献120

  • 1Pillai RS. MicroRNA function: multiple mechanisms for a tiny RNA? RNA 2005; 11:1753-1761.
  • 2Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. Science 2005; 309:1519-1524.
  • 3Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
  • 4Fitzgerald K. RNAi versus small molecules: different mechanisms and specificities can lead to different outcomes. Curr Opin Drug Discov Dev 2005, 8:557-566.
  • 5Brennecke J, Stark A, Russell R.B, Cohen SM. Principles of microRNA-target recognition. PLoS Biol.2005; 3:e85.
  • 6Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122:6-7.
  • 7Chen CZ, Li L, Lodish HF, Bartel DE MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303:83- 86.
  • 8Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006; 94:776-780.
  • 9Hammond SM. MicroRNAs as oncogenes. Curr Opin Genet Dev 2006; 16:4-9.
  • 10Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.

共引文献254

同被引文献40

  • 1CHEN Hong1,CHEN Qun2,FANG Ming3 & MI Yan1 1 The First Affiliated Hospital of Harbin Medical University,Harbin 150101,China,2 Harbin Acheng District People’s Hospital,Harbin 150300,China,3 Graduate Department of Harbin Medical University,Harbin 150001,China.microRNA-181b targets MLK2 in HL-60 cells[J].Science China(Life Sciences),2010,53(1):101-106. 被引量:20
  • 2Chen Y,Orlicky DJ, Matsumoto A, et al. Aldehyde dehydrogenase 1B1(ALDH1B1)is a potential biomarker for human colon cancer. Biochem Biophys Res Commun.2011;405(2):173-179.
  • 3van den Hoogen C,van der Horst G, Cheung H, et al. High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res.2010;70(12):5163-5173.
  • 4Zhang W, Yan W, You G, et al. Genome-wide DNA methylation profiling identifies ALDH1 A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma. Cancer Lett.2013;328(1):120-125.
  • 5Akalay I, Janji B, Hasmim M,et al. Epithelial-to- mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis. Cancer Res.2013;73(8):2418-2427.
  • 6Mao P, Joshi K, Li J, et al. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc Natl Acad Sci USA.2013;110(21):8644-8649.
  • 7El-Khattouti A, Selimovic D, Haikel Y, et al. Identification and analysis of CD133(+)melanoma stem-like cells conferring resistance to taxol: An insight into the mechanisms of their resistance and response. Cancer Lett.2014;343(1):123-133.
  • 8Civenni G,WalterA, Kobert N, et al. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res.2011;71(8):3098-3109.
  • 9Prasmickaite L, Skrbo N, Hoifodt HK, et al. Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells. Pigment Cell Melanoma Res.2010;23(3):449-451.
  • 10Petkova N,Hennenlotter J,Sobiesiak M, et al. Surface CD24 distinguishes between low differentiated and transit-amplifying cells in the basal layer of human prostate. Prostate.2013,73(14):1576-1590.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部